# Cardiff Oncology, Inc.: filings

CRDF · Nasdaq · CIK 1213037 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crdf.md) · [Financials](/companies/crdf/financials.md) · [Filings](/companies/crdf/filings.md) · [Insiders](/companies/crdf/insiders.md)

## Reports and events: 516 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 408, 4 250, 10-Q 45, 3 33, CORRESP 29, SC 13G/A 26, SC 13G 25, DEFA14A 21, UPLOAD 21, 424B5 19, DEF 14A 19, EFFECT 16, 10-K 15, 4/A 14, S-8 13, S-1/A 12, D 11, S-3 8, PRE 14A 7, S-1 7, 8-K/A 6, POS AM 6, 424B3 5, ARS 4, CT ORDER 4, 10-12G/A 3, 424B4 3, S-3/A 2, SC 13D 2, SCHEDULE 13G 2, SCHEDULE 13G/A 2, 10-12G 1, 10-Q/A 1, 25-NSE 1, 8-A12B 1, CERTNAS 1, DEFR14A 1, FWP 1, PRER14A 1, RW 1, S-1MEF 1, S-3ASR 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-11-12 | 16:21 ET | [8-K](/filings/0001193125-26-458500.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-458500 |
| 2026-11-12 | 16:20 ET | [10-Q](/filings/0001193125-26-458485.md) | Quarterly report, period 2026-09-30 | 0001193125-26-458485 |
| 2026-10-27 | 16:44 ET | [8-K](/filings/0001493152-26-048720.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-048720 |
| 2026-10-22 | 16:30 ET | [8-K](/filings/0001493152-26-048111.md) | 5.07 Shareholder vote results | 0001493152-26-048111 |
| 2026-09-14 | 09:28 ET | [8-K](/filings/0001493152-26-042506.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042506 |
| 2026-08-26 | 16:01 ET | [DEF 14A](/filings/0001193125-26-368249.md) | Proxy statement, period 2026-08-26 | 0001193125-26-368249 |
| 2026-08-11 | 16:11 ET | [8-K](/filings/0001193125-26-344645.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344645 |
| 2026-08-11 | 16:01 ET | [10-Q](/filings/0001193125-26-344545.md) | Quarterly report, period 2026-06-30 | 0001193125-26-344545 |
| 2026-07-16 | 08:38 ET | [8-K](/filings/0001193125-26-305467.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-305467 |
| 2026-06-11 | 16:15 ET | [8-K](/filings/0001193125-26-267563.md) | 5.07 Shareholder vote results | 0001193125-26-267563 |
| 2026-06-03 | 08:30 ET | [8-K](/filings/0001193125-26-254658.md) | 7.01 Regulation FD disclosure | 0001193125-26-254658 |
| 2026-05-29 | 17:11 ET | [8-K](/filings/0001193125-26-248711.md) | 1.01 Entry into a material agreement | 0001193125-26-248711 |
| 2026-05-19 | 17:01 ET | [8-K](/filings/0001193125-26-231040.md) | 8.01 Other events | 0001193125-26-231040 |
| 2026-05-14 | 16:15 ET | [8-K](/filings/0001213037-26-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213037-26-000013 |
| 2026-05-14 | 16:00 ET | [10-Q](/filings/0001213037-26-000011.md) | Quarterly report, period 2026-03-31 | 0001213037-26-000011 |
| 2026-04-23 | 16:44 ET | [DEF 14A](/filings/0001213037-26-000006.md) | Proxy statement, period 2026-06-11 | 0001213037-26-000006 |
| 2026-04-09 | 16:10 ET | [8-K](/filings/0001193125-26-149623.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-149623 |
| 2026-04-02 | 16:15 ET | [8-K](/filings/0001193125-26-140152.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors | 0001193125-26-140152 |
| 2026-02-25 | 08:30 ET | [8-K](/filings/0001193125-26-068668.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-068668 |
| 2026-02-24 | 17:09 ET | [8-K](/filings/0001193125-26-067476.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-26-067476 |
| 2026-02-24 | 17:07 ET | [10-K](/filings/0001193125-26-067464.md) | Annual report, period 2025-12-31 | 0001193125-26-067464 |
| 2026-01-27 | 16:01 ET | [8-K](/filings/0001193125-26-024375.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-024375 |
| 2025-11-06 | 16:08 ET | [8-K](/filings/0001193125-25-269492.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269492 |
| 2025-11-06 | 16:00 ET | [10-Q](/filings/0001193125-25-269424.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269424 |
| 2025-07-29 | 16:10 ET | [8-K](/filings/0000950170-25-099631.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events | 0000950170-25-099631 |
| 2025-07-29 | 16:00 ET | [10-Q](/filings/0000950170-25-099610.md) | Quarterly report, period 2025-06-30 | 0000950170-25-099610 |
| 2025-06-26 | 16:30 ET | [8-K](/filings/0001641172-25-016659.md) | 5.07 Shareholder vote results | 0001641172-25-016659 |
| 2025-06-17 | 16:15 ET | [8-K](/filings/0000950170-25-087369.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-087369 |
| 2025-05-08 | 16:10 ET | [8-K](/filings/0000950170-25-066947.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066947 |
| 2025-05-08 | 16:00 ET | [10-Q](/filings/0000950170-25-066886.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066886 |
| 2025-04-29 | 16:00 ET | [DEF 14A](/filings/0000950170-25-060074.md) | Proxy statement, period 2025-04-29 | 0000950170-25-060074 |
| 2025-02-27 | 16:15 ET | [8-K](/filings/0000950170-25-029065.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-029065 |
| 2025-02-27 | 16:00 ET | [10-K](/filings/0000950170-25-028992.md) | Annual report, period 2024-12-31 | 0000950170-25-028992 |
| 2025-01-06 | 16:10 ET | [8-K](/filings/0000950170-25-002076.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-002076 |
| 2024-12-10 | 16:10 ET | [8-K](/filings/0000950170-24-134970.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-134970 |
| 2024-12-10 | 06:02 ET | [8-K](/filings/0000950170-24-134749.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-134749 |
| 2024-11-07 | 16:07 ET | [8-K](/filings/0000950170-24-123303.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123303 |
| 2024-11-07 | 16:00 ET | [10-Q](/filings/0000950170-24-123242.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123242 |
| 2024-08-08 | 16:06 ET | [8-K](/filings/0001628280-24-036122.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-036122 |
| 2024-08-08 | 16:00 ET | [10-Q](/filings/0001628280-24-036098.md) | Quarterly report, period 2024-06-30 | 0001628280-24-036098 |
| 2024-06-20 | 16:03 ET | [8-K](/filings/0001628280-24-029108.md) | 5.07 Shareholder vote results | 0001628280-24-029108 |
| 2024-06-03 | 16:03 ET | [8-K](/filings/0001628280-24-026295.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-026295 |
| 2024-05-02 | 16:10 ET | [8-K](/filings/0001628280-24-020010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-020010 |
| 2024-05-02 | 16:00 ET | [10-Q](/filings/0001628280-24-019974.md) | Quarterly report, period 2024-03-31 | 0001628280-24-019974 |
| 2024-04-25 | 16:02 ET | [DEF 14A](/filings/0001628280-24-018143.md) | Proxy statement, period 2024-06-20 | 0001628280-24-018143 |
| 2024-04-08 | 16:07 ET | [8-K](/filings/0001628280-24-015247.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-015247 |
| 2024-02-29 | 16:08 ET | [8-K](/filings/0001628280-24-007972.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-007972 |
| 2024-02-29 | 16:00 ET | [10-K](/filings/0001628280-24-007948.md) | Annual report, period 2023-12-31 | 0001628280-24-007948 |
| 2024-01-08 | 09:12 ET | [8-K](/filings/0001628280-24-000780.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-000780 |
| 2023-11-02 | 16:06 ET | [8-K](/filings/0001628280-23-036386.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-036386 |

Page 1 of 11. [Older](/companies/crdf/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:10 ET. No prices; not investment advice.
